Hypertrophic cardiomyopathy is a complex cardiac disease withunique pathophysiologic characteristics and a great diversityof morphologic, functional, and clinical features.1,2,3,4,5,6,7,8The heterogeneity of the disease is accentuated by the factthat it afflicts patients of all ages. During the past few years,technological developments in implantable defibrillators andpacemakers have provided new therapeutic options for patientswith the disease.9,10,11,12,13,14,15,16,17,18 In addition, rapidadvances in our knowledge of the molecular defects responsiblefor hypertrophic cardiomyopathy have deepened our understandingof the disorder and have suggested new approaches to the assessmentof prognosis.19,20,21,22 These recent developments, however,have also generated considerable . . . [Full Text of this Article]
Heterogeneity of Clinical and Genetic Features
Treatment of the Symptoms of Heart Failure
Medical Therapy
Pharmacologic Options
Strategies for Drug Therapy
Treatment of Asymptomatic Patients and Prevention of Disease Progression
Management of Atrial Fibrillation
Treatment Options after the Failure of Drug Therapy
Surgery for Relief of Outflow Tract Obstruction and Symptoms
Nonsurgical Techniques for Relief of Outflow Tract Obstruction and Symptoms
Stratification of Risk
Clinical Indicators of Risk
Major Risk Factors
Electrophysiologic Testing
Syncope
Massive Left Ventricular Hypertrophy
Genetic Indicators of Risk
Prevention of Sudden Death
Amiodarone
Implantable Defibrillators
Source Information
From the Servizio di Cardiologia, Ospedale Sant'Andrea, La Spezia, Italy (P.S.); the Howard Hughes Medical Institute and the Cardiovascular Division, Brigham and Women's Hospital, Boston (C.E.S.); the Department of Cardiological Sciences, St. George's Hospital Medical School, London (W.J.M.); and the Minneapolis Heart Institute Foundation, Minneapolis (B.J.M.).
Address reprint requests to Dr. Spirito at the Servizio di Cardiologia, Ospedale Sant'Andrea, Via Veneto 197, La Spezia 19100, Italy.
Bruder, O., Schneider, S., Nothnagel, D., Dill, T., Hombach, V., Schulz-Menger, J., Nagel, E., Lombardi, M., van Rossum, A. C., Wagner, A., Schwitter, J., Senges, J., Sabin, G. V., Sechtem, U., Mahrholdt, H.
(2009). EuroCMR (European Cardiovascular Magnetic Resonance) Registry: Results of the German Pilot Phase. J Am Coll Cardiol
54: 1457-1466
[Abstract][Full Text]
Ahmed, I., Smalley, S. J, Zhu, D. W X, Dahiya, R., House, C. M, Nelson, W. B
(2009). Sudden cardiac arrest in apical hypertrophic cardiomyopathy. BMJ Case Reports
2009: bcr0420091753-bcr0420091753
[Abstract][Full Text]
Delmo Walter, E. M. B., Siniawski, H., Hetzer, R.
(2009). Sustained improvement after combined anterior mitral valve leaflet retention plasty and septal myectomy in preventing systolic anterior motion in hypertrophic obstructive cardiomyopathy in children. Eur. J. Cardiothorac. Surg.
36: 546-552
[Abstract][Full Text]
Ge, Y., Rybakova, I. N., Xu, Q., Moss, R. L.
(2009). Top-down high-resolution mass spectrometry of cardiac myosin binding protein C revealed that truncation alters protein phosphorylation state. Proc. Natl. Acad. Sci. USA
106: 12658-12663
[Abstract][Full Text]
Maron, B. J., Maron, M. S., Wigle, E. D., Braunwald, E.
(2009). The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.. J Am Coll Cardiol
54: 191-200
[Abstract][Full Text]
Maron, M. S., Maron, B. J., Harrigan, C., Buros, J., Gibson, C. M., Olivotto, I., Biller, L., Lesser, J. R., Udelson, J. E., Manning, W. J., Appelbaum, E.
(2009). Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.. J Am Coll Cardiol
54: 220-228
[Abstract][Full Text]
Basso, C., Thiene, G., Mackey-Bojack, S., Frigo, A. C., Corrado, D., Maron, B. J.
(2009). Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death. Eur Heart J
30: 1627-1634
[Abstract][Full Text]
Rawlins, J., Bhan, A., Sharma, S.
(2009). Left ventricular hypertrophy in athletes. Eur J Echocardiogr
10: 350-356
[Abstract][Full Text]
Spirito, P., Autore, C., Rapezzi, C., Bernabo, P., Badagliacca, R., Maron, M. S., Bongioanni, S., Coccolo, F., Estes, N.A. M., Barilla, C. S., Biagini, E., Quarta, G., Conte, M. R., Bruzzi, P., Maron, B. J.
(2009). Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy. Circulation
119: 1703-1710
[Abstract][Full Text]
Sadayappan, S., Gulick, J., Klevitsky, R., Lorenz, J. N., Sargent, M., Molkentin, J. D., Robbins, J.
(2009). Cardiac Myosin Binding Protein-C Phosphorylation in a {beta}-Myosin Heavy Chain Background. Circulation
119: 1253-1262
[Abstract][Full Text]
Soor, G S, Luk, A, Ahn, E, Abraham, J R, Woo, A, Ralph-Edwards, A, Butany, J
(2009). Hypertrophic cardiomyopathy: current understanding and treatment objectives. J. Clin. Pathol.
62: 226-235
[Abstract][Full Text]
Penicka, M., Gregor, P., Kerekes, R., Marek, D., Curila, K., Krupicka, J., for the Candesartan use in Hypertrophic And Non-ob,
(2009). The Effects of Candesartan on Left Ventricular Hypertrophy and Function in Nonobstructive Hypertrophic Cardiomyopathy: A Pilot, Randomized Study. J. Mol. Diagn.
11: 35-41
[Abstract][Full Text]
Brignole, M., Blanc, J.-J., Sutton, R., Moya, A.
(2009). CHAPTER 26 Syncope. ESC Textbook of Cardiovascular Medicine
2: med-9780199566990-chapter-med-9780199566990-chapter
[Abstract][Full Text]
Cuoco, F. A., Spencer, W. H. III, Fernandes, V. L., Nielsen, C. D., Nagueh, S., Sturdivant, J. L., Leman, R. B., Wharton, J. M., Gold, M. R.
(2008). Implantable Cardioverter-Defibrillator Therapy for Primary Prevention of Sudden Death After Alcohol Septal Ablation of Hypertrophic Cardiomyopathy. J Am Coll Cardiol
52: 1718-1723
[Abstract][Full Text]
Maron, M. S., Finley, J. J., Bos, J. M., Hauser, T. H., Manning, W. J., Haas, T. S., Lesser, J. R., Udelson, J. E., Ackerman, M. J., Maron, B. J.
(2008). Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy. Circulation
118: 1541-1549
[Abstract][Full Text]
Zahka, K, Kalidas, K, Simpson, M A, Cross, H, Keller, B B, Galambos, C, Gurtz, K, Patton, M A, Crosby, A H
(2008). Homozygous mutation of MYBPC3 associated with severe infantile hypertrophic cardiomyopathy at high frequency among the Amish. Heart
94: 1326-1330
[Abstract][Full Text]
Prasad, K, Williams, L, Campbell, R, Elliott, P M, McKenna, W J, Frenneaux, M
(2008). Episodic syncope in hypertrophic cardiomyopathy: evidence for inappropriate vasodilation. Heart
94: 1312-1317
[Abstract][Full Text]
Hosokawa, Y., Takano, H., Ohno, T., Takayama, M., Takano, T.
(2008). Impact of Percutaneous Transluminal Septal Myocardial Ablation on Refractory Paroxysmal Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy. ANGIOLOGY
59: 329-334
[Abstract]
Saumarez, R. C., Pytkowski, M., Sterlinski, M., Bourke, J. P., Clague, J. R., Cobbe, S. M., Connelly, D. T., Griffith, M. J., McKeown, P. P., McLeod, K., Morgan, J. M., Sadoul, N., Chojnowska, L., Huang, C. L.-H., Grace, A. A.
(2008). Paced ventricular electrogram fractionation predicts sudden cardiac death in hypertrophic cardiomyopathy. Eur Heart J
29: 1653-1661
[Abstract][Full Text]
Tsoutsman, T., Kelly, M., Ng, D. C.H., Tan, J.-E., Tu, E., Lam, L., Bogoyevitch, M. A., Seidman, C. E., Seidman, J.G., Semsarian, C.
(2008). Severe Heart Failure and Early Mortality in a Double-Mutation Mouse Model of Familial Hypertrophic Cardiomyopathy. Circulation
117: 1820-1831
[Abstract][Full Text]
Fifer, M. A., Vlahakes, G. J.
(2008). Management of Symptoms in Hypertrophic Cardiomyopathy. Circulation
117: 429-439
[Full Text]
ElBardissi, A. W., Dearani, J. A., Nishimura, R. A., Ommen, S. R., Stulak, J. M., Schaff, H. V.
(2007). Septal Myectomy After Previous Septal Artery Ablation in Hypertrophic Cardiomyopathy. Mayo Clin Proc.
82: 1516-1522
[Abstract][Full Text]
Authors/Task Force Members, , Vardas, P. E., Auricchio, A., Blanc, J.-J., Daubert, J.-C., Drexler, H., Ector, H., Gasparini, M., Linde, C., Morgado, F. B., Oto, A., Sutton, R., Trusz-Gluza, M., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Funck-Brentano, C., Filippatos, G., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Priori, S. G., Blomstrom-Lundqvist, C., Brignole, M., Terradellas, J. B., Camm, J., Castellano, P., Cleland, J., Farre, J., Fromer, M., Le Heuzey, J.-Y., Lip, G. Y., Merino, J. L., Montenero, A. S., Ritter, P., Schalij, M. J., Stellbrink, C.
(2007). Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association. Europace
9: 959-998
[Full Text]
Authors/Task Force Members, , Vardas, P. E., Auricchio, A., Blanc, J.-J., Daubert, J.-C., Drexler, H., Ector, H., Gasparini, M., Linde, C., Morgado, F. B., Oto, A., Sutton, R., Trusz-Gluza, M., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Funck-Brentano, C., Filippatos, G., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Priori, S. G., Blomstrom-Lundqvist, C., Brignole, M., Terradellas, J. B., Camm, J., Castellano, P., Cleland, J., Farre, J., Fromer, M., Le Heuzey, J.-Y., Lip, G. Y., Merino, J. L., Montenero, A. S., Ritter, P., Schalij, M. J., Stellbrink, C.
(2007). Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association. Eur Heart J
28: 2256-2295
[Full Text]
Williams, L., Frenneaux, M.
(2007). Syncope in hypertrophic cardiomyopathy: mechanisms and consequences for treatment. Europace
9: 817-822
[Abstract][Full Text]
Maron, B. J., Spirito, P., Shen, W.-K., Haas, T. S., Formisano, F., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Lawrenz, T., Boriani, G., Estes, N. A. M. III, Favale, S., Piccininno, M., Winters, S. L., Santini, M., Betocchi, S., Arribas, F., Sherrid, M. V., Buja, G., Semsarian, C., Bruzzi, P.
(2007). Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy. JAMA
298: 405-412
[Abstract][Full Text]
Kubo, T., Gimeno, J. R., Bahl, A., Steffensen, U., Steffensen, M., Osman, E., Thaman, R., Mogensen, J., Elliott, P. M., Doi, Y., McKenna, W. J.
(2007). Prevalence, Clinical Significance, and Genetic Basis of Hypertrophic Cardiomyopathy With Restrictive Phenotype. J Am Coll Cardiol
49: 2419-2426
[Abstract][Full Text]
Petersen, S. E., Jerosch-Herold, M., Hudsmith, L. E., Robson, M. D., Francis, J. M., Doll, H. A., Selvanayagam, J. B., Neubauer, S., Watkins, H.
(2007). Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy: New Insights From Multiparametric Magnetic Resonance Imaging. Circulation
115: 2418-2425
[Abstract][Full Text]
Barrick, C. J., Rojas, M., Schoonhoven, R., Smyth, S. S., Threadgill, D. W.
(2007). Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal- and background-dependent development of concentric left ventricular hypertrophy. Am. J. Physiol. Heart Circ. Physiol.
292: H2119-H2130
[Abstract][Full Text]
Maron, M. S., Olivotto, I., Zenovich, A. G., Link, M. S., Pandian, N. G., Kuvin, J. T., Nistri, S., Cecchi, F., Udelson, J. E., Maron, B. J.
(2006). Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction. Circulation
114: 2232-2239
[Abstract][Full Text]
Sadayappan, S., Osinska, H., Klevitsky, R., Lorenz, J. N., Sargent, M., Molkentin, J. D., Seidman, C. E., Seidman, J. G., Robbins, J.
(2006). Cardiac myosin binding protein c phosphorylation is cardioprotective. Proc. Natl. Acad. Sci. USA
103: 16918-16923
[Abstract][Full Text]
Crump, S. M., Correll, R. N., Schroder, E. A., Lester, W. C., Finlin, B. S., Andres, D. A., Satin, J.
(2006). L-type calcium channel {alpha}-subunit and protein kinase inhibitors modulate Rem-mediated regulation of current. Am. J. Physiol. Heart Circ. Physiol.
291: H1959-H1971
[Abstract][Full Text]
Developed in Collaboration With the European Heart, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L.
(2006). ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol
48: 1064-1108
[Full Text]
Developed in Collaboration With the European Heart, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L.
(2006). ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol
48: e247-e346
[Full Text]
Zipes, D. P., Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L., ACC/AHA (Practice Guidelines) Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2006). ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.. Eur Heart J
27: 2099-2140
[Full Text]
Writing Committee Members, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L., ACC/AHA Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2006). ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace
8: 746-837
[Full Text]
Elliott, P. M., Gimeno, J. R., Tome, M. T., Shah, J., Ward, D., Thaman, R., Mogensen, J., McKenna, W. J.
(2006). Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J
27: 1933-1941
[Abstract][Full Text]
D'Andrea, A., Caso, P., Severino, S., Cuomo, S., Capozzi, G., Calabro, P., Cice, G., Ascione, L., Scherillo, M., Calabro, R.
(2006). Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy. Eur Heart J
27: 1311-1318
[Abstract][Full Text]
Spirito, P., Autore, C.
(2006). Management of hypertrophic cardiomyopathy.. BMJ
332: 1251-1255
[Full Text]
Yoerger, D. M., Best, C. A., McQuillan, B. M., Supple, G. E., Guererro, J. L., Cluette-Brown, J. E., Hasaba, A., Picard, M. H., Stone, J. R., Laposata, M.
(2006). Rapid Fatty Acid Ethyl Ester Synthesis by Porcine Myocardium Upon Ethanol Infusion into the Left Anterior Descending Coronary Artery. Am. J. Pathol.
168: 1435-1442
[Abstract][Full Text]
D'Andrea, A, Caso, P, Cuomo, S, Salerno, G, Scarafile, R, Mita, C, De Corato, G, Sarubbi, B, Scherillo, M, Calabro, R, Citro, R
(2006). Prognostic value of intra-left ventricular electromechanical asynchrony in patients with mild hypertrophic cardiomyopathy compared with power athletes * Commentary.. Br. J. Sports. Med.
40: 244-250
[Abstract][Full Text]
Strickberger, S. A., Benson, D. W., Biaggioni, I., Callans, D. J., Cohen, M. I., Ellenbogen, K. A., Epstein, A. E., Friedman, P., Goldberger, J., Heidenreich, P. A., Klein, G. J., Knight, B. P., Morillo, C. A., Myerburg, R. J., Sila, C. A.
(2006). AHA/ACCF Scientific Statement on the Evaluation of Syncope: From the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation In Collaboration With the Heart Rhythm Society. J Am Coll Cardiol
47: 473-484
[Full Text]
Strickberger, S. A., Benson, D. W., Biaggioni, I., Callans, D. J., Cohen, M. I., Ellenbogen, K. A., Epstein, A. E., Friedman, P., Goldberger, J., Heidenreich, P. A., Klein, G. J., Knight, B. P., Morillo, C. A., Myerburg, R. J., Sila, C. A.
(2006). AHA/ACCF Scientific Statement on the Evaluation of Syncope: From the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: In Collaboration With the Heart Rhythm Society: Endorsed by the American Autonomic Society. Circulation
113: 316-327
[Full Text]
Perkins, M. J., Van Driest, S. L., Ellsworth, E. G., Will, M. L., Gersh, B. J., Ommen, S. R., Ackerman, M. J.
(2005). Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy. Eur Heart J
26: 2457-2462
[Abstract][Full Text]
Kubo, T., Kitaoka, H., Okawa, M., Matsumura, Y., Hitomi, N., Yamasaki, N., Furuno, T., Takata, J., Nishinaga, M., Kimura, A., Doi, Y. L.
(2005). Lifelong Left Ventricular Remodeling of Hypertrophic Cardiomyopathy Caused by a Founder Frameshift Deletion Mutation in the Cardiac Myosin-Binding Protein C Gene Among Japanese. J Am Coll Cardiol
46: 1737-1743
[Abstract][Full Text]
Biagini, E., Coccolo, F., Ferlito, M., Perugini, E., Rocchi, G., Bacchi-Reggiani, L., Lofiego, C., Boriani, G., Prandstraller, D., Picchio, F. M., Branzi, A., Rapezzi, C.
(2005). Dilated-Hypokinetic Evolution of Hypertrophic Cardiomyopathy: Prevalence, Incidence, Risk Factors, and Prognostic Implications in Pediatric and Adult Patients. J Am Coll Cardiol
46: 1543-1550
[Abstract][Full Text]
Ingles, J, Doolan, A, Chiu, C, Seidman, J, Seidman, C, Semsarian, C
(2005). Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J. Med. Genet.
42: e59-e59
[Abstract][Full Text]
Binder, W. D., Fifer, M. A., King, M. E., Stone, J. R.
(2005). Case 26-2005 - A 48-Year-Old Man with Sudden Loss of Consciousness while Jogging. NEJM
353: 824-832
[Full Text]
Ommen, S. R., Maron, B. J., Olivotto, I., Maron, M. S., Cecchi, F., Betocchi, S., Gersh, B. J., Ackerman, M. J., McCully, R. B., Dearani, J. A., Schaff, H. V., Danielson, G. K., Tajik, A. J., Nishimura, R. A.
(2005). Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol
46: 470-476
[Abstract][Full Text]
Mahrholdt, H., Wagner, A., Judd, R. M., Sechtem, U., Kim, R. J.
(2005). Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J
26: 1461-1474
[Abstract][Full Text]
van der Lee, C., ten Cate, F. J., Geleijnse, M. L., Kofflard, M. J., Pedone, C., van Herwerden, L. A., Biagini, E., Vletter, W. B., Serruys, P. W.
(2005). Percutaneous Versus Surgical Treatment for Patients With Hypertrophic Obstructive Cardiomyopathy and Enlarged Anterior Mitral Valve Leaflets. Circulation
112: 482-488
[Abstract][Full Text]
Autore, C., Bernabo, P., Barilla, C. S., Bruzzi, P., Spirito, P.
(2005). The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. J Am Coll Cardiol
45: 1076-1080
[Abstract][Full Text]
Wall, M., Calvert, C. A., Sanderson, S. L., Leonhardt, A., Barker, C., Fallaw, T. K.
(2005). Evaluation of Extended-Release Diltiazem Once Daily for Cats With Hypertrophic Cardiomyopathy. Journal of the American Animal Hospital Association
41: 98-103
[Abstract][Full Text]
Adabag, A. S., Casey, S. A., Kuskowski, M. A., Zenovich, A. G., Maron, B. J.
(2005). Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol
45: 697-704
[Abstract][Full Text]
Arad, M., Maron, B. J., Gorham, J. M., Johnson, W. H. Jr., Saul, J. P., Perez-Atayde, A. R., Spirito, P., Wright, G. B., Kanter, R. J., Seidman, C. E., Seidman, J.G.
(2005). Glycogen Storage Diseases Presenting as Hypertrophic Cardiomyopathy. NEJM
352: 362-372
[Abstract][Full Text]
Kaufmann, P. A., Camici, P. G.
(2005). Myocardial Blood Flow Measurement by PET: Technical Aspects and Clinical Applications. JNM
46: 75-88
[Full Text]
Maron, B. J., Dearani, J. A., Ommen, S. R., Maron, M. S., Schaff, H. V., Gersh, B. J., Nishimura, R. A.
(2004). The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol
44: 2044-2053
[Abstract][Full Text]
Boriani, G., Maron, B. J., Shen, W.-K., Spirito, P.
(2004). Prevention of Sudden Death in Hypertrophic Cardiomyopathy: But Which Defibrillator for Which Patient?. Circulation
110: e438-e442
[Full Text]
Wernicke, D., Thiel, C., Duja-Isac, C. M., Essin, K. V., Spindler, M., Nunez, D. J. R., Plehm, R., Wessel, N., Hammes, A., Edwards, R.-J., Lippoldt, A., Zacharias, U., Stromer, H., Neubauer, S., Davies, M. J., Morano, I., Thierfelder, L.
(2004). {alpha}-Tropomyosin mutations Asp175Asn and Glu180Gly affect cardiac function in transgenic rats in different ways. Am. J. Physiol. Regul. Integr. Comp. Physiol.
287: R685-R695
[Abstract][Full Text]
Murata, M., Cingolani, E., McDonald, A. D., Donahue, J. K., Marban, E.
(2004). Creation of a Genetic Calcium Channel Blocker by Targeted Gem Gene Transfer in the Heart. Circ. Res.
95: 398-405
[Abstract][Full Text]
Van Driest, S. L., Jaeger, M. A., Ommen, S. R., Will, M. L., Gersh, B. J., Tajik, A. J., Ackerman, M. J.
(2004). Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol
44: 602-610
[Abstract][Full Text]
Task Force Members, , Lopez-Sendo, J., Swedberg, K., McMurray, J., Tamargo, J., Maggioni, A. P., Dargie, H., Tendera, M., Waagstein, F., Kjekshus, J., Lechat, P., Pedersen, C. T., ESC Committee for Practice Guidelines, , Priori, S. G., Alonso Garcia, M. A., Blanc, J.-J., Budaj, A., Cowie, M., Dean, V., Deckers, J., Fernandez Burgos, E., Lekakis, J., Lindahl, B., Mazzotta, G., McGregor, K., Morais, J., Oto, A., Smiseth, O. A., Document Reviewers, , Alonso Garcia, M. A., Ardissino, D., Avendano, C., Lundqvist, C. B., ment, D. C., Drexler, H., Ferrari, R., Fox, K. A., Julian, D., Kearney, P., Klein, W., ber, L. K., Mancia, G., Nieminen, M., Ruzyllo, W., Simoons, M., Thygesen, K., Tognoni, G., Tritto, I., Wallentin, L.
(2004). Expert consensus document on {beta}-adrenergic receptor blockers: The Task Force on Beta-Blockers of the European Society of Cardiology. Eur Heart J
25: 1341-1362
[Full Text]
Tong, C. W., Gaffin, R. D., Zawieja, D. C., Muthuchamy, M.
(2004). Roles of phosphorylation of myosin binding protein-C and troponin I in mouse cardiac muscle twitch dynamics. J. Physiol.
558: 927-941
[Abstract][Full Text]
Borer, J. S.
(2004). Left ventricular hypertrophy in hypertrophic cardiomyopathy: What's in a phenotype?. J Am Coll Cardiol
44: 406-408
[Full Text]
Gietzen, F H, Leuner, C J, Obergassel, L, Strunk-Mueller, C, Kuhn, H
(2004). Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients. Heart
90: 638-644
[Abstract][Full Text]
Flashman, E., Redwood, C., Moolman-Smook, J., Watkins, H.
(2004). Cardiac Myosin Binding Protein C: Its Role in Physiology and Disease. Circ. Res.
94: 1279-1289
[Abstract][Full Text]
Wever, E. F. D., Robles de Medina, E. O.
(2004). Sudden death in patients without structural heart disease. J Am Coll Cardiol
43: 1137-1144
[Abstract][Full Text]
Nishimura, R. A., Holmes, D. R. Jr.
(2004). Hypertrophic Obstructive Cardiomyopathy. NEJM
350: 1320-1327
[Full Text]
van Dockum, W. G., ten Cate, F. J., ten Berg, J. M., Beek, A. M., Twisk, J. W. R., Vos, J., Hofman, M. B. M., Visser, C. A., van Rossum, A. C.
(2004). Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol
43: 27-34
[Abstract][Full Text]
Rovner, A., Smith, R., Greenberg, N. L., Tuzcu, E. M., Smedira, N., Lever, H. M., Thomas, J. D., Garcia, M. J.
(2003). Improvement in diastolic intraventricular pressure gradients in patients with HOCM after ethanol septal reduction. Am. J. Physiol. Heart Circ. Physiol.
285: H2492-H2499
[Abstract][Full Text]
Sorajja, P., Ommen, S. R., Nishimura, R. A., Gersh, B. J., Berger, P. B., Tajik, A. J.
(2003). Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease. Circulation
108: 2342-2348
[Abstract][Full Text]
Maron, B. J., McKenna, W. J., Danielson, G. K., Kappenberger, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H. III, Spirito, P., Ten Cate, F. J., Wigle, E. D., Vogel, R. A., Abrams, J., Bates, E. R., Brodie, B. R., Danias, P. G., Gregoratos, G., Hlatky, M. A., Hochman, J. S., Kaul, S., Lichtenberg, R. C., Lindner, J. R., O'rourke, R. A., Pohost, G. M., Schofield, R. S., Tracy, C. M., Winters, W. L. Jr, Klein, W. W., Priori, S. G., Alonso-Garcia, A., Blomstrom-Lundqvist, C., De Backer, G., Deckers, J., Flather, M., Hradec, J., Oto, A., Parkhomenko, A., Silber, S., Torbicki, A.
(2003). American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol
42: 1687-1713
[Full Text]
Writing Committee Members, , Maron, B. J., McKenna, W. J., Danielson, G. K., Kappenberger, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H. III, Spirito, P., Ten Cate, F. J., Wigle, E. D., ACCF Task Force on Clinical Expert Consensus Docum, , Vogel, R. A., Abrams, J., Bates, E. R., Brodie, B. R., Danias, P. G., Gregoratos, G., Hlatky, M. A., Hochman, J. S., Kaul, S., Lichtenberg, R. C., Lindner, J. R., O'Rourke, R. A., Pohost, G. M., Schofield, R. S., Tracy, C. M., Winters, W. L. Jr, ESC Committee for Practice Guidelines Members, , Klein, W. W., Priori, S. G., Alonso-Garcia, A., Blomstrom-Lundqvist, C., De Backer, G., Deckers, J., Flather, M., Hradec, J., Oto, A., Parkhomenko, A., Silber, S., Torbicki, A.
(2003). American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J
24: 1965-1991
[Full Text]
Antezano, E. S., Hong, M.
(2003). Sudden Cardiac Death. J Intensive Care Med
18: 313-329
[Abstract]
van der Lee, C., Kofflard, M. J.M., van Herwerden, L. A., Vletter, W. B., ten Cate, F. J.
(2003). Sustained Improvement After Combined Anterior Mitral Leaflet Extension and Myectomy in Hypertrophic Obstructive Cardiomyopathy. Circulation
108: 2088-2092
[Abstract][Full Text]
Cecchi, F., Olivotto, I., Gistri, R., Lorenzoni, R., Chiriatti, G., Camici, P. G.
(2003). Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy. NEJM
349: 1027-1035
[Abstract][Full Text]
Monserrat, L., Elliott, P. M., Gimeno, J. R., Sharma, S., Penas-Lado, M., McKenna, W. J.
(2003). Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol
42: 873-879
[Abstract][Full Text]
Maron, B. J., Casey, S. A., Hauser, R. G., Aeppli, D. M.
(2003). Clinical course of hypertrophiccardiomyopathy with survival to advanced age. J Am Coll Cardiol
42: 882-888
[Abstract][Full Text]
Schmitt, J. P., Semsarian, C., Arad, M., Gannon, J., Ahmad, F., Duffy, C., Lee, R. T., Seidman, C. E., Seidman, J.G.
(2003). Consequences of Pressure Overload on Sarcomere Protein Mutation-Induced Hypertrophic Cardiomyopathy. Circulation
108: 1133-1138
[Abstract][Full Text]
Van Driest, S. L., Ellsworth, E. G., Ommen, S. R., Tajik, A. J., Gersh, B. J., Ackerman, M. J.
(2003). Prevalence and Spectrum of Thin Filament Mutations in an Outpatient Referral Population With Hypertrophic Cardiomyopathy * Note Added in Proof. Circulation
108: 445-451
[Abstract][Full Text]
Chang, S. M., Nagueh, S. F., Spencer, W. H. III, Lakkis, N. M.
(2003). Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol
42: 296-300
[Abstract][Full Text]
Firoozi, S, Sharma, S, McKenna, W J
(2003). Risk of competitive sport in young athletes with heart disease. Heart
89: 710-714
[Abstract][Full Text]
Sato, Y, Taniguchi, R, Nagai, K, Makiyama, T, Okada, H, Yamada, T, Matsumori, A, Takatsu, Y
(2003). Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy. Heart
89: 659-660
[Full Text]
Saumarez, R. C., Chojnowska, L., Derksen, R., Pytkowski, M., Sterlinski, M., Huang, C. L.-H., Sadoul, N., Hauer, R. N.W., Ruzyllo, W., Grace, A. A.
(2003). Sudden Death in Noncoronary Heart Disease Is Associated With Delayed Paced Ventricular Activation. Circulation
107: 2595-2600
[Abstract][Full Text]
Moon, J. C. C., McKenna, W. J., McCrohon, J. A., Elliott, P. M., Smith, G. C., Pennell, D. J.
(2003). Toward clinical risk assessment inhypertrophic cardiomyopathy withgadolinium cardiovascular magnetic resonance. J Am Coll Cardiol
41: 1561-1567
[Abstract][Full Text]